In 2023, Medicare selected 10 drugs for its first round of price negotiations. Agreements were reached with drug manufacturers to establish new, reduced prices for all 10 drugs. These prices ...

About 65 million are covered by Medicare. The drugs selected for price negotiations are among those with "highest total spending" for Medicare Part D, according to the White House. When the new ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for Medicare price negotiations for 2027. Novo Nordisk's blockbuster diabetes drug ...

President Trump has signed his executive order seeking lower prescription drug prices. It gives the pharmaceutical industry ...

This change would mean that small molecule drugs would be on the market longer before they are eligible to be selected for Medicare drug price negotiation, which could lead to higher Medicare ...

Kennedy Jr. to work with Congress to modify a piece of the Medicare drug price negotiation rules, which differentiate between small-molecule drugs and biologic medicines. Get top local stories in ...

When should six drugs count as one ... And the answer could have major ramifications for the Medicare drug price negotiation program, a signature accomplishment of former President Biden that ...

Such a change has the potential to increase costs for the government, because it would most likely delay the existing timetable for some drugs to become eligible for Medicare price cuts.